THE MECHANISM OF THE EMETIC ACTION OF SODIUM SALICYLATE

Area of Science:

• Pharmacology
• Neuroscience
• Gastroenterology

Background:

• The emetic effects of sodium salicylate are well-documented.
• Understanding the neural pathways involved in salicylate-induced emesis is crucial for managing adverse drug reactions.

Purpose of the Study:

• To elucidate the neural mechanisms underlying the emetic response to intravenous and oral sodium salicylate in dogs.
• To differentiate the roles of the chemoreceptor trigger zone, vagus nerve, and spinal pathways in salicylate-induced vomiting.

Main Methods:

• Determined the emetic dose 50 (ED50) for intravenous and oral sodium salicylate in dogs.
• Performed ablations of the chemoreceptor trigger zone, supradiaphragmatic vagotomy, and spinal transection to assess their effects on emesis.
• Observed the latency and completeness of emetic responses following surgical interventions.

Main Results:

• Sodium salicylate induced emesis with ED50 values of 256 mg/kg (IV) and 228 mg/kg (PO).
• Chemoreceptor trigger zone ablation provided complete protection against IV salicylate but only partial protection against PO salicylate.
• Vagotomy resulted in equal protection against both routes, while spinal transection offered partial protection.

Conclusions:

• The study suggests distinct neural pathways for intravenous and oral sodium salicylate-induced emesis.
• Further research is needed to definitively determine whether vagal pathways are common or if vagal afferents prime the vomiting center.